CN1346675A - Chinese patent medicine for treating paraplegia - Google Patents

Chinese patent medicine for treating paraplegia Download PDF

Info

Publication number
CN1346675A
CN1346675A CN01141625A CN01141625A CN1346675A CN 1346675 A CN1346675 A CN 1346675A CN 01141625 A CN01141625 A CN 01141625A CN 01141625 A CN01141625 A CN 01141625A CN 1346675 A CN1346675 A CN 1346675A
Authority
CN
China
Prior art keywords
parts
gram
paraplegia
chinese patent
patent medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN01141625A
Other languages
Chinese (zh)
Other versions
CN1184992C (en
Inventor
戚晓峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011416254A priority Critical patent/CN1184992C/en
Publication of CN1346675A publication Critical patent/CN1346675A/en
Application granted granted Critical
Publication of CN1184992C publication Critical patent/CN1184992C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

A Chinese patent medicine for treating paraplegia is prepared from 12 Chinese-medicinal materials including astragalus root, leech, placenta, notoginseng, etc through pulverizing, mixing with boiled honey, and shaping honeyed pills or particles. It has high curative effect.

Description

The Chinese patent medicine of treatment paraplegia
Technical field
The present invention relates to a kind of medicine for the treatment of paraplegia, specifically is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Background technology
At present, the prevention that spinal cord injury causes paraplegia and treatment are one of important topics of current medical science and biology, Physiologic Studies, and Chinese scholars is all being explored and studied.Yet, all there are not obviously progress and effective Therapeutic Method up to now, therefore, spinal cord injury causes the patient of paraplegia can be found everywhere, and brings huge misery for countless families.
Summary of the invention
Technical problem to be solved by this invention just provides a kind of novel pure Chinese medicinal preparation, effectively treats paraplegia, recovers function convenient to both, promotes the spinal cord growth, makes it have the cure rate height, determined curative effect, and take characteristics such as have no side effect for a long time.
Medicine of the present invention is to make (consumption is a weight portion) by following component Chinese patent medicine honeyed pill or granule method for making routinely:
5~15 parts of 5~15 fens Asterias amurensis Lutkenes of 10~20 parts of Placenta Hominiss of 10~25 portions of Hirudos of the Radix Astragali
10~25 parts in 10~25 parts of Rhizoma Gastrodiaes of 5~15 parts of Radix Rehmanniaes Preparata of 5~15 parts of Ovum Eriocheir sinensis of Radix Notoginseng
5~15 parts of 5~15 parts of Cordyceps of 5~10 parts of Rhizoma Chuanxiongs of 5~10 parts of Ligamentum cervis of eupolyphage sece steleophaga
4~10 parts of Sanguis Draxonis
The present invention adopts traditional theory of Chinese medical science, and in conjunction with Zhitan secret recipe handed down from one's ancestors, the pure Chinese medicinal preparation of the effective drug development of repeated screening, have evident in efficacy, taking convenience, low price, and advantage such as without any side effects is the comparatively ideal medicine for the treatment of paraplegia at present.
Below provide three formulation Example of the present invention:
Side one, the Radix Astragali 13 gram Hirudos 13 gram Placenta Hominiss 7 gram Asterias amurensis Lutkenes 7 grams
Radix Notoginseng 7 gram Ovum Eriocheir sinensis 7 gram Radix Rehmanniaes Preparata 8 gram Rhizoma Gastrodiaes 11 grams
Eupolyphage sece steleophaga 6 gram Ligamentum cervis 6 gram Rhizoma Chuanxiongs 6 gram Cordyceps 6 grams
Sanguis Draxonis 7 grams
Side two, the Radix Astragali 15 gram Hirudos 14 gram Placenta Hominiss 9 gram Asterias amurensis Lutkenes 8 grams
Radix Notoginseng 8 gram Ovum Eriocheir sinensis 8 gram Radix Rehmanniaes Preparata 9 gram Rhizoma Gastrodiaes 13 grams
Eupolyphage sece steleophaga 6.5 gram Ligamentum cervis 6.5 gram Rhizoma Chuanxiongs 6.5 gram Cordyceps 6.5 grams
Sanguis Draxonis 10 grams
Side three, the Radix Astragali 18 gram Hirudos 15 gram Placenta Hominiss 11 gram Asterias amurensis Lutkenes 9 grams
Radix Notoginseng 10 gram Ovum Eriocheir sinensis 10 gram Radix Rehmanniaes Preparata 11 gram Rhizoma Gastrodiaes 15 grams
Eupolyphage sece steleophaga 8 gram Ligamentum cervis 7 gram Rhizoma Chuanxiongs 7 gram Cordyceps 8 grams
Sanguis Draxonis 4 grams
By above-mentioned formulation Example as can be seen, solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of motherland's medical science to " paraplegia ", achieve with reference to modern pharmacological research, from motherland's medicine treasure-house, filter out invigorating the kidney and strengthening the bones, the removing blood stasis dissipating blood stasis, channels sootheing and network vessel quickening, honor repose through natural plant, by the theory of Chinese medical science prescription, skim the cream off milk.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, to select the pure natural plant medicine be raw material in the present invention, and each component meets the pharmaceutical control law regulation. Sharp With the comprehensive function treatment " paraplegia " of each flavor Chinese medicine, no chemical analysis, nontoxic to human body.
2, the present invention need not decoct, no bitterness sense, taking convenience.
3, during the drug administration of the present invention, the combination with massaging effect can be more remarkable again, can when taking Do efficacy-enhancing ingredient with about 5 gram donkey-hide gelatin, curative effect can be more remarkable.

Claims (1)

1, a kind of Chinese patent medicine for the treatment of paraplegia is characterized in that it is honeyed pill or the granule of being made by following proportion raw material.
5~15 parts of 5~15 fens Asterias amurensis Lutkenes of 10~20 parts of Placenta Hominiss of 10~25 portions of Hirudos of the Radix Astragali
10~25 parts in 10~25 parts of Rhizoma Gastrodiaes of 5~15 parts of Radix Rehmanniaes Preparata of 5~15 parts of Ovum Eriocheir sinensis of Radix Notoginseng
5~15 parts of 5~15 parts of Cordyceps of 5~10 parts of Rhizoma Chuanxiongs of 5~10 parts of Ligamentum cervis of eupolyphage sece steleophaga
4~10 parts of Sanguis Draxonis
CNB011416254A 2001-09-29 2001-09-29 Chinese patent medicine for treating paraplegia Expired - Fee Related CN1184992C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011416254A CN1184992C (en) 2001-09-29 2001-09-29 Chinese patent medicine for treating paraplegia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011416254A CN1184992C (en) 2001-09-29 2001-09-29 Chinese patent medicine for treating paraplegia

Publications (2)

Publication Number Publication Date
CN1346675A true CN1346675A (en) 2002-05-01
CN1184992C CN1184992C (en) 2005-01-19

Family

ID=4676287

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011416254A Expired - Fee Related CN1184992C (en) 2001-09-29 2001-09-29 Chinese patent medicine for treating paraplegia

Country Status (1)

Country Link
CN (1) CN1184992C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1308025C (en) * 2005-03-10 2007-04-04 介晓东 Medicine for treating paraplegia and its preparing method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1308025C (en) * 2005-03-10 2007-04-04 介晓东 Medicine for treating paraplegia and its preparing method

Also Published As

Publication number Publication date
CN1184992C (en) 2005-01-19

Similar Documents

Publication Publication Date Title
CN101732683A (en) Chinese medicinal preparation for treating facial chloasma and preparation method thereof
CN1203805A (en) Health-care drink capable of preventing and curing menopathy
CN1223359C (en) Kidney-reinforcing blood-activating wine
CN101129852A (en) Oral liquid for regulating the flow of Qi and pacifying the mind
CN105311492A (en) Medicine for treating coronary atherosclerotic heart disease
CN1742626A (en) Sea-buckthorn licorice tablet and preparing technology
CN1184992C (en) Chinese patent medicine for treating paraplegia
CN100531789C (en) Chinese medicine for treating injury
CN100411666C (en) Broad-specturm medicine for treating snake venom poisoning
CN1285378C (en) Nourishing wine for regulating human body balance function
CN101129512A (en) Zegui oral liquid
CN1164294C (en) Liver cancer resisting medicine
CN1129447C (en) Anshen pill-treating cardio-cerebral angiopathy
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN101129610A (en) Vitality raising pill of glutinous rehmannia
CN1259359A (en) Xiongsanxian medicinal wine contg. bear bile and pseudo ginseng and its prepn. technology
CN1850160A (en) Qidantongmai Tablet, and its preparing process
CN1262295C (en) Health care medicine capable of strengthening heart and kidney function and immunologic function
CN1059120C (en) Chinese medicine for treating bone wound
CN1062172C (en) Medicine for treating cervical spondylopathy
CN1185007C (en) Blood-lipid-reducing thrombolytic medicine
CN1186036C (en) Diabetes treating medicine and its prepn
CN1209125C (en) Diabetes treating medicine
CN1218738C (en) Prepared Chinese internal medicine for promoting blood circulation to stop pain
CN1488382A (en) Health-care medicine for preventing and curing cardio-cerebrovascular diseae

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee